Oncology Institute, Inc. Net Cash Provided by (Used in) Financing Activities in USD from Q4 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oncology Institute, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2019 to Q1 2025.
  • Oncology Institute, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$4.74M, a 405% decline year-over-year.
  • Oncology Institute, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$3.49M, a 49% increase from 2023.
  • Oncology Institute, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$6.85M, a 107% decline from 2022.
  • Oncology Institute, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $92.2M, a 40.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Oncology Institute, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$4.74M -$3.8M -405% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 -$938K +$771K +45.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 -$1.71M -$52K -3.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$1.66M -$24.1M -107% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $22.4M -$209M -90.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $232M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-28
Q4 2019 $25K Nov 1, 2019 Dec 31, 2019 10-K/A 2021-12-14

Oncology Institute, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3.49M +$3.36M +49% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 -$6.85M -$99.1M -107% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $92.2M -$61.8M -40.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $154M +$142M +1196% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $11.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.